This weekend my friend Keith will be meeting with his group of investors and they have very good connections with CHINA and the regulatory agencies and the major players in the Pharma space and he will let me know about these Asian Partners of ACCP who they really are and if this is going to be a real money maker
In a previous agreement, Access and Rhei Pharmaceuticals HK Ltd had signed a USD30m supply agreement for MuGard, ensuring manufacturing capacity of up to a minimum of USD30m in the licensed territories.
In conjunction, the approval of a sub-license agreement between RHEI Pharmaceuticals and Jian An Pharmaceuticals (Jian An) Limited in Shenzhen, China will leverage Jian An's extensive sales, marketing and regulatory infrastructure for the launch of MuGard in China and Taiwan.
Keith Do your connections know anything about these 2 companies that ACCESS has Partnered with?
TIME TO FIND OUT WHEN WE GET A STOCKING ORDER AND HOW MANY DOLLARS IT WILL BE